Literature DB >> 18830871

Angiokeratomas of Fabry successfully treated with intense pulsed light.

Paulo Morais1, António Luís Santos, Teresa Baudrier, Alberto Vieira Mota, João Paulo Oliveira, Filomena Azevedo.   

Abstract

Fabry disease (FD) is a rare X-linked lysosomal storage disorder resulting from the deficient activity of the enzyme alpha-galactosidase A. Angiokeratomas (AKs) are a frequent manifestation of this disease. They usually become apparent during childhood and can cause important cosmetic disability. Current treatment of this feature in the setting of FD has been mainly based on the application of laser systems, namely the argon laser, the variable pulse width 532-nm Nd:YAG laser, the 578-nm copper vapor laser and the flashlamp-pumped pulsed dye laser. We report the case of a 31-year-old Caucasian woman with a clinical and molecular (GLA p.R118C) diagnosis of FD, presenting multiple AKs scattered over the buttocks and thighs. She was treated with 10 sessions of intense pulsed light (IPL), with a 4-8-week interval between them. An almost complete clearance of the lesions was obtained, with no scars or significant complaints. No recurrence occurred during a 12-month follow-up period. The IPL source can be considered a suitable, effective and safe treatment modality for these cutaneous lesions that typically affect patients with FD, with no need for local anesthesia and with very satisfactory cosmetic results. To our best knowledge, there are no reports in the literature of Fabry's AKs treated with IPL.

Entities:  

Mesh:

Year:  2008        PMID: 18830871     DOI: 10.1080/14764170802275832

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  5 in total

1.  Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma.

Authors:  Susana Ferreira; Christiane Auray-Blais; Michel Boutin; Pamela Lavoie; José Pedro Nunes; Elisabete Martins; Scott Garman; João Paulo Oliveira
Journal:  Clin Chim Acta       Date:  2015-06-09       Impact factor: 3.786

2.  The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.

Authors:  Susana Ferreira; Alberto Ortiz; Dominique P Germain; Miguel Viana-Baptista; António Caldeira-Gomes; Marta Camprecios; Maria Fenollar-Cortés; Ángel Gallegos-Villalobos; Diego Garcia; José Antonio García-Robles; Jesús Egido; Eduardo Gutiérrez-Rivas; José Antonio Herrero; Sebastián Mas; Raluca Oancea; Paloma Péres; Luis Manuel Salazar-Martín; Jesús Solera-Garcia; Helena Alves; Scott C Garman; João Paulo Oliveira
Journal:  Mol Genet Metab       Date:  2014-11-09       Impact factor: 4.797

3.  Frequency of Fabry disease in male and female haemodialysis patients in Spain.

Authors:  Paulo Gaspar; Julio Herrera; Daniel Rodrigues; Sebastián Cerezo; Rodrigo Delgado; Carlos F Andrade; Ramón Forascepi; Juan Macias; Maria D del Pino; Maria D Prados; Pilar R de Alegria; Gerardo Torres; Pedro Vidau; Maria C Sá-Miranda
Journal:  BMC Med Genet       Date:  2010-02-01       Impact factor: 2.103

4.  Effect of intense pulsed light on the expression of aquaporin 3 in rat skin.

Authors:  Cheng-Jung Wu; Chien-Chung Chen; Hsiang-Shun Shih; Li-Ren Chang; Chih-Hsin Liu; Yi-Tien Liu; Pin-Hsuan Lin; Wen-Shyan Huang; Seng-Feng Jeng; Guan-Ming Feng
Journal:  Lasers Med Sci       Date:  2015-08-01       Impact factor: 3.161

5.  Photoepilation and Skin Photorejuvenation: An Update.

Authors:  Alessandro Martella; Mauro Raichi
Journal:  Dermatol Reports       Date:  2017-06-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.